Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParvus En Regulatory News (AEET)

Share Price Information for Parvus En (AEET)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
23.00
Ask:
27.00
Spread: 4.00 (17.391%)
Market Cap: £20.36m
AEET Live PriceLast checked at - London Stock Exchange

Intraday Parvus En Share Chart

First Day of Dealings

2 Jun 2021 08:00

RNS Number : 4996A
Aquila Energy Efficiency Trust PLC
02 June 2021
 

2 June 2021

 

LEI: 213800AJ3TY3OJCQQC53

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION IS UNLAWFUL, OR TO ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN TO PROFESSIONAL INVESTORS IN CERTAIN EEA MEMBER STATES FOR WHICH MARKETING APPROVAL HAS BEEN OBTAINED)

 

Aquila Energy Efficiency Trust PLC

(the "Company")

 

First day of dealings

 

Aquila Energy Efficiency Trust PLC is pleased to announce the commencement of dealings in its Ordinary Shares at 8:00 a.m. today on the premium segment of the main market of the London Stock Exchange and admission to the premium segment of the Official List of the Financial Conduct Authority ("Admission").

 

The Company's issued ordinary share capital immediately following Admission will comprise 100,000,000 Ordinary Shares and this is the total number of Ordinary Shares with voting rights in the Company. This figure (100,000,000) should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Dealing codes

 

The dealing codes for the Ordinary Shares will be as follows:

 

Sterling Quote

Euro Quote

ISIN

GB00BN6JYS78

GB00BN6JYS78

SEDOL

BN6JYS7

BL6K7R6

Ticker

AEET

AEEE

 

Director participation

 

Immediately following Admission, the beneficial interests of the Directors in the issued share capital of the Company will be as follows:

 

Director

Number of ordinary shares

% of issued share capital

Miriam Greenwood

24,000

0.024%

Lisa Arnold

20,100

0.020%

Laura Sandys

15,000

0.015%

Nicholas Bliss

20,000

0.020%

 

For further information please contact:

 

Aquila Capital

 

Via Buchanan

Peel Hunt (Sole Sponsor, Placing Agent and Intermediaries Offer Adviser) Luke Simpson, Huw Jeremy, Tom Pocock (Investment Banking)

Alex Howe, Chris Bunstead, Ed Welsby, Richard Harris (Sales)

Alistair Boyle (Intermediaries)

Sohail Akbar (ECM)

 

020 7418 8900

Buchanan (Financial PR)

Charles Ryland, Henry Wilson

 

020 7466 5000

 

All capitalised terms used and not defined herein shall have the same meaning as in the Prospectus.

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUARKRARUNRAR
Date   Source Headline
3rd Jun 20261:00 pmRNSResult of AGM
24th Apr 20267:00 amRNSAnnual Financial Report
21st Apr 20263:30 pmRNSChange of Name
13th Apr 20267:00 amRNSNew management arrangements
2nd Feb 20267:00 amRNSChange of Corporate Broker
13th Jan 202612:30 pmRNSHolding(s) in Company
17th Dec 202511:32 amRNSRemoval of Euro Quote
9th Dec 202511:45 amRNSHolding(s) in Company
8th Dec 20253:30 pmRNSHolding(s) in Company
2nd Dec 202512:15 pmRNSHolding(s) in Company
19th Nov 202511:30 amRNSHolding(s) in Company
13th Nov 20255:38 pmRNSDirector/PDMR Shareholding
31st Oct 20253:00 pmRNSHolding(s) in Company
7th Oct 20251:15 pmRNSHolding(s) in Company
23rd Sep 20257:01 amRNSHalf-year Report
23rd Sep 20257:00 amRNSDividend Declaration
10th Sep 202512:00 pmRNSHolding(s) in Company
12th Aug 20256:00 pmRNSHolding(s) in Company
1st Aug 202510:30 amRNSHolding(s) in Company
23rd Jun 202510:01 amRNSHolding(s) in Company
11th Jun 202510:45 amRNSHolding(s) in Company
9th Jun 20253:45 pmRNSHolding(s) in Company
4th Jun 20255:00 pmRNSHolding(s) in Company
28th May 20254:00 pmRNSResult of AGM
7th May 20252:30 pmRNSHolding(s) in Company
1st May 20257:00 amRNSNotice of AGM
29th Apr 20257:05 amRNSSpecial Interim Dividend Declaration
29th Apr 20257:00 amRNSAnnual Financial Report
12th Mar 20259:33 amRNSHolding(s) in Company
10th Mar 20255:24 pmRNSHolding(s) in Company
28th Feb 20254:07 pmRNSRealisation of certain investments
6th Jan 20258:50 amRNSHolding(s) in Company
19th Dec 20242:11 pmRNSHolding(s) in Company
17th Dec 20244:23 pmRNSHolding(s) in Company
18th Nov 20247:00 amRNSChange of registered office
13th Nov 20244:49 pmRNSDirector/PDMR Shareholding
27th Sep 20247:02 amRNSDividend Declaration
27th Sep 20247:00 amRNSHalf-year Report
26th Jul 20243:35 pmRNSHolding(s) in Company
21st Jun 20247:00 amRNSBoard Committee membership change
13th Jun 20247:00 amRNSResult of AGM
31st May 20244:26 pmRNSTotal Voting Rights
20th May 20246:08 pmRNSDirector/PDMR Shareholding
20th May 202412:06 pmRNSHolding(s) in Company
20th May 202411:37 amRNSDirector/PDMR Shareholding
17th May 20243:07 pmRNSHolding(s) in Company
16th May 20243:10 pmRNSHolding(s) in Company
16th May 20243:09 pmRNSHolding(s) in Company
15th May 20245:45 pmRNSDirector/PDMR Shareholding
13th May 202412:31 pmRNSResults of General Meeting and Tender Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.